<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38177128</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>04</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Muscle abnormalities worsen after post-exertional malaise in long COVID.</ArticleTitle><Pagination><StartPage>17</StartPage><MedlinePgn>17</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-44432-3</ELocationID><Abstract><AbstractText>A subgroup of patients infected with SARS-CoV-2 remain symptomatic over three months after infection. A distinctive symptom of patients with long COVID is post-exertional malaise, which is associated with a worsening of fatigue- and pain-related symptoms after acute mental or physical exercise, but its underlying pathophysiology is unclear. With this longitudinal case-control study (NCT05225688), we provide new insights into the pathophysiology of post-exertional malaise in patients with long COVID. We show that skeletal muscle structure is associated with a lower exercise capacity in patients, and local and systemic metabolic disturbances, severe exercise-induced myopathy and tissue infiltration of amyloid-containing deposits in skeletal muscles of patients with long COVID worsen after induction of post-exertional malaise. This study highlights novel pathways that help to understand the pathophysiology of post-exertional malaise in patients suffering from long COVID and other post-infectious diseases.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Appelman</LastName><ForeName>Brent</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4560-8410</Identifier><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, Infectious diseases, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Charlton</LastName><ForeName>Braeden T</ForeName><Initials>BT</Initials><Identifier Source="ORCID">0000-0002-4242-3664</Identifier><AffiliationInfo><Affiliation>Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Movement Sciences, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goulding</LastName><ForeName>Richie P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Movement Sciences, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerkhoff</LastName><ForeName>Tom J</ForeName><Initials>TJ</Initials><Identifier Source="ORCID">0000-0002-4046-2504</Identifier><AffiliationInfo><Affiliation>Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Movement Sciences, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breedveld</LastName><ForeName>Ellen A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0009-0006-2516-0694</Identifier><AffiliationInfo><Affiliation>Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Movement Sciences, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noort</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Movement Sciences, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Offringa</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Movement Sciences, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloemers</LastName><ForeName>Frank W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Amsterdam Movement Sciences, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Trauma Surgery, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Weeghel</LastName><ForeName>Michel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4916-2866</Identifier><AffiliationInfo><Affiliation>Laboratory Genetic Metabolic Diseases, Core Facility Metabolomics, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schomakers</LastName><ForeName>Bauke V</ForeName><Initials>BV</Initials><AffiliationInfo><Affiliation>Laboratory Genetic Metabolic Diseases, Core Facility Metabolomics, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coelho</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Neurologia, Departamento de Neuroci&#xea;ncias e Sa&#xfa;de Mental, Hospital de Santa Maria, CHULN, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculdade de Medicina, Centro de Estudos Egas Moniz, University of Lisbon, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of (Neuro)pathology, Amsterdam Neuroscience, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posthuma</LastName><ForeName>Jelle J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Trauma Surgery, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flevoziekenhuis, Division of Surgery, Hospitaalweg 1, Almere, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronica</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3542-3770</Identifier><AffiliationInfo><Affiliation>Department of (Neuro)pathology, Amsterdam Neuroscience, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joost Wiersinga</LastName><ForeName>W</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-2277-1343</Identifier><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, Infectious diseases, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>van Vugt</LastName><ForeName>Mich&#xe8;le</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, Infectious diseases, Amsterdam, the Netherlands. m.vanvugt@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tropical Medicine, Department of Medicine, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands. m.vanvugt@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>W&#xfc;st</LastName><ForeName>Rob C I</ForeName><Initials>RCI</Initials><Identifier Source="ORCID">0000-0003-3781-5177</Identifier><AffiliationInfo><Affiliation>Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. r.wust@vu.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Movement Sciences, Amsterdam, the Netherlands. r.wust@vu.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05225688</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009139" MajorTopicYN="Y">Musculoskeletal Abnormalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38177128</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-44432-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, Mccorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333:575&#x2013;578. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M, Paiva B, Montero-Mateo R, Garcia N, Zabaleta A. Epstein-Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front. Immunol. 2021;12:4637. doi: 10.3389/fimmu.2021.656797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursinus J, et al. Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study. Lancet Reg. Health&#x2014;Eur. 2021;6:100142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8454881</ArticleId><ArticleId IdType="pubmed">34557833</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge MS, Azoulay &#xc9;. Outcomes after critical illness. N. Engl. J. Med. 2023;388:913&#x2013;924. doi: 10.1056/NEJMra2104669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2104669</ArticleId><ArticleId IdType="pubmed">36884324</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerkhoff TJ, Charlton BT, Appelman B, van Vugt M, W&#xfc;st RCI. Post COVID&#x2010;19 condition: critical need for a clear definition and detailed pathophysiology. J. Cachexia Sarcopenia Muscle. 2022;13:2754&#x2013;2756. doi: 10.1002/jcsm.13108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.13108</ArticleId><ArticleId IdType="pmc">PMC9745497</ArticleId><ArticleId IdType="pubmed">36251474</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilunga FP, et al. Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study. Lancet Reg. Health Eur. 2023;29:100630. doi: 10.1016/j.lanepe.2023.100630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100630</ArticleId><ArticleId IdType="pmc">PMC10079482</ArticleId><ArticleId IdType="pubmed">37261215</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, J. et al. Distinguishing features of Long COVID identified through immune profiling. Nature 1&#x2013;3 (2023) 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l EK, et al. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology. Eur. J. Neurol. 2022;29:2832&#x2013;2841. doi: 10.1111/ene.15435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:1&#x2013;18. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri, J. et al. Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nat. Immunol. 1&#x2013;8 (2023) 10.1038/s41590-023-01445-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10063443</ArticleId><ArticleId IdType="pubmed">36879067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 2022;21:1&#x2013;23. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, et al. Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection. EBioMedicine. 2023;94:104729. doi: 10.1016/j.ebiom.2023.104729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104729</ArticleId><ArticleId IdType="pmc">PMC10406961</ArticleId><ArticleId IdType="pubmed">37506544</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares MN, et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J. Cachexia Sarcopenia Muscle. 2022;13:11&#x2013;22. doi: 10.1002/jcsm.12896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12896</ArticleId><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition. (2023)</Citation></Reference><Reference><Citation>Fr&#xe9;sard I, et al. Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in &#x2018;long COVID&#x2019; patients with persistent dyspnoea. BMJ Open Respir. Res. 2022;9:e001126. doi: 10.1136/bmjresp-2021-001126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001126</ArticleId><ArticleId IdType="pmc">PMC8968537</ArticleId><ArticleId IdType="pubmed">35354589</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwendinger F, Knaier R, Radtke T, Schmidt-Trucks&#xe4;ss A. Low cardiorespiratory fitness post-COVID-19: a narrative review. Sports Med. 2023;53:51&#x2013;74. doi: 10.1007/s40279-022-01751-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-022-01751-7</ArticleId><ArticleId IdType="pmc">PMC9483283</ArticleId><ArticleId IdType="pubmed">36115933</ArticleId></ArticleIdList></Reference><Reference><Citation>Skj&#xf8;rten I, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur. Respir. J. 2021;58:2100996. doi: 10.1183/13993003.00996-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00996-2021</ArticleId><ArticleId IdType="pmc">PMC8247555</ArticleId><ArticleId IdType="pubmed">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2022;7:e157621. doi: 10.1172/jci.insight.157621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.157621</ArticleId><ArticleId IdType="pmc">PMC9090259</ArticleId><ArticleId IdType="pubmed">35358096</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor NR, Armstrong CW, Lewis DP, Gooley PR. Post-exertional malaise is associated with hypermetabolism, hypoacetylation and purine metabolism deregulation in ME/CFS cases. Diagnostics. 2019;9:1&#x2013;11. doi: 10.3390/diagnostics9030070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030070</ArticleId><ArticleId IdType="pmc">PMC6787670</ArticleId><ArticleId IdType="pubmed">31277442</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, et al. An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int. J. Mol. Sci. 2020;21:1074. doi: 10.3390/ijms21031074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031074</ArticleId><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xfc;st RCI, et al. The antibiotic doxycycline impairs cardiac mitochondrial and contractile function. Int. J. Mol. Sci. 2021;22:4100. doi: 10.3390/ijms22084100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22084100</ArticleId><ArticleId IdType="pmc">PMC8071362</ArticleId><ArticleId IdType="pubmed">33921053</ArticleId></ArticleIdList></Reference><Reference><Citation>Beloborodova N, et al. Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophils. J. Biomed. Sci. 2012;19:89. doi: 10.1186/1423-0127-19-89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-19-89</ArticleId><ArticleId IdType="pmc">PMC3503878</ArticleId><ArticleId IdType="pubmed">23061754</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedley AM, Pareek V, Benkovic SJ. The purinosome: a case study for a mammalian metabolon. Annu. Rev. Biochem. 2022;91:89&#x2013;106. doi: 10.1146/annurev-biochem-032620-105728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-032620-105728</ArticleId><ArticleId IdType="pmc">PMC9531488</ArticleId><ArticleId IdType="pubmed">35320684</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley M, et al. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat. Commun. 2022;13:3387. doi: 10.1038/s41467-022-30932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman, T. et al. Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. acta neuropathol commun.11, 193 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10704838</ArticleId><ArticleId IdType="pubmed">38066589</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahira K, Hisata S, Choi AMK. The roles of mitochondrial damage-associated molecular patterns in diseases. Antioxid. Redox Signal. 2015;23:1329. doi: 10.1089/ars.2015.6407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2015.6407</ArticleId><ArticleId IdType="pmc">PMC4685486</ArticleId><ArticleId IdType="pubmed">26067258</ArticleId></ArticleIdList></Reference><Reference><Citation>Grazioli S, Pugin J. Mitochondrial damage-associated molecular patterns: from inflammatory signaling to human diseases. Front. Immunol. 2018;9:1. doi: 10.3389/fimmu.2018.00832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00832</ArticleId><ArticleId IdType="pmc">PMC5946030</ArticleId><ArticleId IdType="pubmed">29780380</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 2022;14:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect. Dis. 2023;23:393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E, et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am. J. Respir. Crit. Care Med. 2022;205:126&#x2013;129. doi: 10.1164/rccm.202108-1903LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1903LE</ArticleId><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Colosio M, et al. Structural and functional impairments of skeletal muscle in patients with postacute sequelae of SARS-CoV-2 infection. J. Appl. Physiol. 2023;135:902&#x2013;917. doi: 10.1152/japplphysiol.00158.2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00158.2023</ArticleId><ArticleId IdType="pubmed">37675472</ArticleId></ArticleIdList></Reference><Reference><Citation>Posthuma JJ, van der Meijden PEJ, ten Cate H, Spronk HMH. Short- and long-term exercise induced alterations in haemostasis: a review of the literature. Blood Rev. 2015;29:171&#x2013;178. doi: 10.1016/j.blre.2014.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2014.10.005</ArticleId><ArticleId IdType="pubmed">25467962</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front. Cardiovasc. Med. 2021;8:745758. doi: 10.3389/fcvm.2021.745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, et al. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021;78:948&#x2013;960. doi: 10.1001/jamaneurol.2021.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2004</ArticleId><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mageriu V, Zurac S, Bastian A, Staniceanu F, Manole E. Histological findings in skeletal muscle of SARS-CoV2 infected patient. J. Immunoass. Immunochem. 2020;41:1000&#x2013;1009. doi: 10.1080/15321819.2020.1863819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2020.1863819</ArticleId><ArticleId IdType="pubmed">33353460</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front. Immunol. 2022;12:5526. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, et al. Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies. Lancet Microbe. 2023;4:e745&#x2013;e756. doi: 10.1016/S2666-5247(23)00115-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00115-5</ArticleId><ArticleId IdType="pmc">PMC10292824</ArticleId><ArticleId IdType="pubmed">37385286</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B, et al. Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination. EBioMedicine. 2021;72:103561. doi: 10.1016/j.ebiom.2021.103589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103589</ArticleId><ArticleId IdType="pmc">PMC8461365</ArticleId><ArticleId IdType="pubmed">34571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595:426&#x2013;431. doi: 10.1038/s41586-021-03696-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03696-9</ArticleId><ArticleId IdType="pmc">PMC8277577</ArticleId><ArticleId IdType="pubmed">34126625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallais F, et al. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021;71:103561. doi: 10.1016/j.ebiom.2021.103561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103561</ArticleId><ArticleId IdType="pmc">PMC8390300</ArticleId><ArticleId IdType="pubmed">34455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickse PW, et al. Capillary rarefaction during bed rest is proportionally less than fibre atrophy and loss of oxidative capacity. J. Cachexia Sarcopenia Muscle. 2022;13:2712&#x2013;2723. doi: 10.1002/jcsm.13072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.13072</ArticleId><ArticleId IdType="pmc">PMC9745458</ArticleId><ArticleId IdType="pubmed">36102002</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard J, et al. Myopathy as a cause of Long COVID fatigue: evidence from quantitative and single fiber EMG and muscle histopathology. Clin. Neurophysiol. 2023;148:65&#x2013;75. doi: 10.1016/j.clinph.2023.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2023.01.010</ArticleId><ArticleId IdType="pubmed">36804609</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzuto DA, et al. Lung perfusion assessment in children with long-COVID: a pilot study. Pediatr. Pulmonol. 2023;58:2059&#x2013;2067. doi: 10.1002/ppul.26432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26432</ArticleId><ArticleId IdType="pubmed">37097045</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason LA. A brief questionnaire to assess post-exertional malaise. Diagnostics. 2018;8:66. doi: 10.3390/diagnostics8030066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics8030066</ArticleId><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, Alvarez LA, Larocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch. Neurol. 1988;45:435&#x2013;437. doi: 10.1001/archneur.1988.00520280085020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1988.00520280085020</ArticleId><ArticleId IdType="pubmed">3355400</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets EMA, Garssen B, Bonke B, De Haes JCJM. The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995;39:315&#x2013;325. doi: 10.1016/0022-3999(94)00125-O.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType="pubmed">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Clevenger KA, et al. Effect of sampling rate on acceleration and counts of hip- and wrist-worn ActiGraph accelerometers in children. Physiol. Meas. 2019;40:095008. doi: 10.1088/1361-6579/ab444b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1361-6579/ab444b</ArticleId><ArticleId IdType="pubmed">31518999</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnaiger E. (2020) Mitochondrial pathways and respiratory control. An introduction to OXPHOS analysis. 5th ed. Bioenerg Commun 2:112 (2020).</Citation></Reference><Reference><Citation>Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int. J. Biochem. Cell Biol. 2009;41:1837&#x2013;1845. doi: 10.1016/j.biocel.2009.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2009.03.013</ArticleId><ArticleId IdType="pubmed">19467914</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnaiger E, et al. Mitochondrial coupling and capacity of oxidative phosphorylation in skeletal muscle of Inuit and Caucasians in the arctic winter. Scand. J. Med. Sci. Sports. 2015;25:126&#x2013;134. doi: 10.1111/sms.12612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sms.12612</ArticleId><ArticleId IdType="pubmed">26589126</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwath O, et al. Variability in vastus lateralis fiber type distribution, fiber size, and myonuclear content along and between the legs. J. Appl. Physiol. 2021;131:158&#x2013;173. doi: 10.1152/japplphysiol.00053.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00053.2021</ArticleId><ArticleId IdType="pubmed">34013752</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xfc;st RCI, et al. Region-specific adaptations in determinants of rat skeletal muscle oxygenation to chronic hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2009;297:H364&#x2013;74. doi: 10.1152/ajpheart.00272.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00272.2009</ArticleId><ArticleId IdType="pubmed">19429822</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Zwaard S, et al. Critical determinants of combined sprint and endurance performance: an integrative analysis from muscle fiber to the human body. FASEB J. 2018;32:2110&#x2013;2123. doi: 10.1096/fj.201700827R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700827R</ArticleId><ArticleId IdType="pubmed">29217665</ArticleId></ArticleIdList></Reference><Reference><Citation>Grootemaat AE, et al. Lipid and nucleocapsid N-protein accumulation in COVID-19 patient lung and infected cells. Microbiol. Spectr. 2022;10:e0127121. doi: 10.1128/spectrum.01271-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01271-21</ArticleId><ArticleId IdType="pmc">PMC8849100</ArticleId><ArticleId IdType="pubmed">35171025</ArticleId></ArticleIdList></Reference><Reference><Citation>Schomakers BV, et al. Polar metabolomics in human muscle biopsies using a liquid&#x2013;liquid extraction and full-scan LC&#x2013;MS. STAR Protoc. 2022;3:101302. doi: 10.1016/j.xpro.2022.101302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2022.101302</ArticleId><ArticleId IdType="pmc">PMC9035783</ArticleId><ArticleId IdType="pubmed">35479116</ArticleId></ArticleIdList></Reference><Reference><Citation>Daimon, T. Box&#x2013;Cox transformation. Int. Encycl. Stat. Sci.1, 176&#x2013;1781 (2011).</Citation></Reference><Reference><Citation>Diedenhofen B, Musch J. cocor: a comprehensive solution for the statistical comparison of correlations. PLoS ONE. 2015;10:e0121945. doi: 10.1371/journal.pone.0121945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0121945</ArticleId><ArticleId IdType="pmc">PMC4383486</ArticleId><ArticleId IdType="pubmed">25835001</ArticleId></ArticleIdList></Reference><Reference><Citation>Searle SR, Speed FM, Milliken GA. Estimated marginal means, aka least-squares means [R package emmeans version 1.8.5] Am. Stat. 2023;34:216&#x2013;221.</Citation></Reference><Reference><Citation>Hedges LV. Distribution Theory for Glass&#x2019;s estimator of effect size and related estimators. J. Educ. Stat. 1981;6:107&#x2013;128. doi: 10.3102/10769986006002107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3102/10769986006002107</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>